Case 8-2013: A 48-year-old woman with carcinoma in situ of the breast

New England Journal of Medicine

Volumn 368, Issue 11, 2013, Pages 1046-1053

  Morrow, Monica ^a,b   Winograd, Jonathan M ^c,d   Freer, Phoebe E ^c,d   Eichhorn, John H ^c,d  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; ARTICLE; BREAST BIOPSY; CASE REPORT; DIGITAL MAMMOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; IMAGE RECONSTRUCTION; INTRADUCTAL CARCINOMA; MAMMOGRAPHY; PARTIAL MASTECTOMY; PRIORITY JOURNAL; THREE DIMENSIONAL IMAGING; TOMOSYNTHESIS; TUMOR LOCALIZATION; TUMOR VOLUME; BREAST; BREAST RECONSTRUCTION; BREAST TUMOR; CARCINOMA IN SITU; CLINICAL OBSERVATION; CLINICAL STUDY; DIAGNOSIS; MASTECTOMY; MIDDLE AGED; PATHOLOGY; RADIOGRAPHY; SEGMENTAL MASTECTOMY;

BREAST; BREAST NEOPLASMS; CARCINOMA IN SITU; FEMALE; HUMANS; MAMMAPLASTY; MAMMOGRAPHY; MASTECTOMY; MASTECTOMY, SEGMENTAL; MIDDLE AGED;

MLCS; MLOWN;

EID: 84874963740     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcpc1214221     Document Type: Article

References (39)

1. Niklason LT, Christian BT, Niklason LE, et al. Digital tomosynthesis in breast imaging. Radiology 1997;205:399-406. (Pubitemid 27467317)
2. Niklason LT, Kopans DB, Hamberg LM. Digital breast imaging: tomosynthesis and digital subtraction mammography. Breast Dis 1998;10:151-64. (Pubitemid 28470210)
3. Wu T, Moore RH, Kopans DB. Voting strategy for artifact reduction in digital breast tomosynthesis. Med Phys 2006;33:2461-71. (Pubitemid 43967234)
4. Kopans D, Gavenonis S, Halpern E, Moore R. Calcifications in the breast and digital breast tomosynthesis. Breast J 2011;17:638-44.
5. Rafferty EA, Park JM, Philpotts LE, et al. Assessing radiologist performance using combined digital mammography and breast tomosynthesis compared with digital mammography alone: results of a multicenter, multireader trial. Radiology 2013;266:104-13.
6. Skaane P, Bandos AI, Gullien R, et al. Comparison of digital mammography alone and digital mammography plus tomosynthesis in a population-based screening program. Radiology 2013 January 7 (Epub ahead of print).
7. Boyages J, Delaney G, Taylor R. Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis. Cancer 1999;85:616-28. (Pubitemid 29075283)
8. Carlson GW, Page A, Johnson E, Nicholson K, Styblo TM, Wood WC. Local recurrence of ductal carcinoma in situ after skin-sparing mastectomy. J Am Coll Surg 2007;204:1074-8. (Pubitemid 46661213)
9. Greenway RM, Schlossberg L, Dooley WC. Fifteen-year series of skin-sparing mastectomy for stage 0 to 2 breast cancer. Am J Surg 2005;190:918-22. (Pubitemid 41674624)
10. Rusby JE, Smith BL, Gui GP. Nipple-sparing mastectomy. Br J Surg 2010;97:305-16.
11. Bijker N, Meijnen P, Peterse JL, et al. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853 - a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol 2006;24:3381-7. (Pubitemid 46638893)
12. Cuzick J, Sestak I, Pinder SE, et al. Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial. Lancet Oncol 2011;12:21-9.
13. Holmberg L, Garmo H, Granstrand B, et al. Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breast. J Clin Oncol 2008;26:1247-52.
14. Wapnir IL, Dignam JJ, Fisher B, et al. Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. J Natl Cancer Inst 2011;103:478-88.
15. Correa C, McGale P, Taylor C, et al. Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr 2010;2010:162-77.
16. Hughes LL, Wang M, Page DL, et al. Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group. J Clin Oncol 2009;27:5319-24.
17. Allred DC, Anderson SJ, Paik S, et al. Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24. J Clin Oncol 2012;30:1268-73.
18. Dunne C, Burke JP, Morrow M, Kell MR. Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ. J Clin Oncol 2009;27:1615-20.
19. Morrow M, Jagsi R, Alderman AK, et al. Surgeon recommendations and receipt of mastectomy for treatment of breast cancer. JAMA 2009;302:1551-6.
20. Bleicher RJ, Ciocca RM, Egleston BL, et al. Association of routine pretreatment magnetic resonance imaging with time to surgery, mastectomy rate, and margin status. J Am Coll Surg 2009;209:180-7. [Erratum, J Am Coll Surg 2009;209:679.]
21. Peters NH, van Esser S, van den Bosch MA, et al. Preoperative MRI and surgical management in patients with nonpalpable breast cancer: the MONET - randomised controlled trial. Eur J Cancer 2011;47:879-86.
22. Schiller DE, Le LW, Cho BC, Youngson BJ, McCready DR. Factors associated with negative margins of lumpectomy specimen: potential use in selecting patients for intraoperative radiotherapy. Ann Surg Oncol 2008;15:833-42.
23. Turnbull LW, Brown SR, Olivier C, et al. Multicentre randomised controlled trial examining the cost-effectiveness of contrast-enhanced high field magnetic resonance imaging in women with primary breast cancer scheduled for wide local excision (COMICE). Health Technol Assess 2010;14:1-182.
24. American College of Radiology. Practice guideline for the breast conservation therapy in the management of invasive breast carcinoma. J Am Coll Surg 2007;205:362-76.
25. Katz SJ, Lantz PM, Janz NK, et al. Patient involvement in surgery treatment decisions for breast cancer. J Clin Oncol 2005;23:5526-33.
26. Gao X, Fisher SG, Emami B. Risk of second primary cancer in the contralateral breast in women treated for earlystage breast cancer: a population-based study. Int J Radiat Oncol Biol Phys 2003;56:1038-45. (Pubitemid 36794035)
27. Colwell AS, Damjanovic B, Zahedi B, Medford-Davis L, Hertl C, Austen WG Jr. Retrospective review of 331 consecutive immediate single-stage implant reconstructions with acellular dermal matrix: indications, complications, trends, and costs. Plast Reconstr Surg 2011;128:1170-8.
28. Gamboa-Bobadilla GM. Implant breast reconstruction using acellular dermal matrix. Ann Plast Surg 2006;56:22-5. (Pubitemid 43042268)
29. Topol BM, Dalton EF, Ponn T, Campbell CJ. Immediate single-stage breast reconstruction using implants and human acellular dermal tissue matrix with adjustment of the lower pole of the breast to reduce unwanted lift. Ann Plast Surg 2008;61:494-9.
30. Kobraei EM, Nimtz J, Wong L, et al. Risk factors for adverse outcome following skin-sparing mastectomy and immediate prosthetic reconstruction. Plast Reconstr Surg 2012;129(2):234e-241e.
31. Chun YS, Verma K, Rosen H, et al. Implant-based breast reconstruction using acellular dermal matrix and the risk of postoperative complications. Plast Reconstr Surg 2010;125:429-36.
32. Roostaeian J, Pavone L, Da Lio A, Lipa J, Festekjian J, Crisera C. Immediate placement of implants in breast reconstruction: patient selection and outcomes. Plast Reconstr Surg 2011;127:1407-16.
33. Salgarello M, Visconti G, Barone-Adesi L. Nipple-sparing mastectomy with immediate implant reconstruction: cosmetic outcomes and technical refinements. Plast Reconstr Surg 2010;126:1460-71.
34. Solin LJ, Kurtz J, Fourquet A, et al. Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast. J Clin Oncol 1996;14:754-63. (Pubitemid 26085518)
35. King TA, Sakr R, Patil S, et al. Clinical management factors contribute to the decision for contralateral prophylactic mastectomy. J Clin Oncol 2011;29:2158-64.
36. Yao K, Stewart AK, Winchester DJ, Winchester DP. Trends in contralateral prophylactic mastectomy for unilateral cancer: a report from the National Cancer Data Base, 1998-2007. Ann Surg Oncol 2010;17:2554-62.
37. Hawley ST, Jagsi R, Morrow M, Katz SJ. Correlates of contralateral prophylactic mastectomy in a population-based sample. J Clin Oncol 2011;29:Suppl:6010. abstract.
38. Morrow M, Schmidt RA, Bucci C. Breast conservation for mammographically occult carcinoma. Ann Surg 1998;227:502-6. (Pubitemid 28363265)
39. Yang TJ, Yang Q, Haffty BG, Moran MS. Prognosis for mammographically occult, early-stage breast cancer patients treated with breast-conservation therapy. Int J Radiat Oncol Biol Phys 2010;76:79-84.